Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BLACU

Bellevue Life Sciences A... (BLACU)

Bellevue Life Sciences Acquisition Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BLACU
DateTimeSourceHeadlineSymbolCompany
22/02/202408:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
14/02/202401:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
09/02/202408:20Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
06/02/202405:48Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
17/11/202309:00PR Newswire (US)OSR Holdings Co., Ltd. Enters Into Business Combination Agreement with Bellevue Life Sciences Acquisition Corp.NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
17/11/202308:37Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
17/11/202308:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
15/11/202322:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
08/11/202308:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
21/10/202307:20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
11/10/202308:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
15/08/202306:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
12/07/202306:58Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
12/07/202306:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
12/07/202306:45PR Newswire (US)Bellevue Life Sciences Acquisition Corp. and OSR Holdings Sign an Exclusive Letter of Intent for a Business CombinationNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
29/06/202306:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
15/06/202307:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
23/05/202306:35Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
16/05/202322:01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
01/04/202307:20Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
28/03/202307:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
28/03/202307:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
28/03/202307:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
15/03/202307:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
15/03/202307:05PR Newswire (US)Bellevue Life Sciences Acquisition Corp. Announces Separate Trading of its Shares of Common Stock, Warrants and Rights Commencing March 17, 2023NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
01/03/202309:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
24/02/202308:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
22/02/202308:05PR Newswire (US)Bellevue Life Sciences Acquisition Corp. Announces Closing of Full Over-allotment OptionNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
15/02/202308:05PR Newswire (US)Bellevue Life Sciences Acquisition Corp. Announces Closing of $60 Million Initial Public OfferingNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:BLACU